News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
735,573 Results
Type
Article (42361)
Company Profile (275)
Press Release (692923)
Multimedia
Podcasts (86)
Webinars (21)
Section
Business (207316)
Career Advice (2041)
Deals (35962)
Drug Delivery (121)
Drug Development (81713)
Employer Resources (173)
FDA (16667)
Job Trends (15093)
News (350253)
Policy (33068)
Tag
2027 BioCapital Elite (1)
2027 Biotech Bay Standard (2)
2027 Genetown Elite (2)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (3)
Academia (2629)
Accelerated approval (42)
Adcomms (25)
Allergies (161)
Alliances (50498)
ALS (192)
Alzheimer's disease (1761)
Antibody-drug conjugate (ADC) (367)
Approvals (16984)
Artificial intelligence (613)
Autoimmune disease (224)
Automation (50)
Bankruptcy (366)
Best Places to Work (11707)
BIOSECURE Act (20)
Biosimilars (201)
Biotechnology (176)
Bladder cancer (177)
Brain cancer (63)
Breast cancer (695)
Cancer (5348)
Cardiovascular disease (442)
Career advice (1730)
Career pathing (40)
CAR-T (300)
CDC (54)
Celiac Disease (2)
Cell therapy (798)
Cervical cancer (42)
Clinical research (70397)
Collaboration (1899)
Company closure (4)
Compensation (1273)
Complete response letters (69)
COVID-19 (2751)
CRISPR (100)
C-suite (983)
Cystic fibrosis (149)
Data (7063)
Decentralized trials (3)
Denatured (26)
Depression (154)
Dermatology (57)
Diabetes (551)
Diagnostics (7242)
Digital health (53)
Diversity (12)
Diversity, equity & inclusion (45)
Drug discovery (295)
Drug pricing (194)
Drug shortages (29)
Duchenne muscular dystrophy (266)
Earnings (91875)
Editorial (60)
Employer branding (21)
Employer resources (152)
Events (119670)
Executive appointments (1043)
FDA (20102)
Fibrodysplasia Ossificans Progressiva (7)
Friedreich's ataxia (14)
Frontotemporal dementia (29)
Funding (1626)
Gene editing (212)
Generative AI (56)
Gene therapy (654)
GLP-1 (1016)
Government (4738)
Grass and pollen (6)
Guidances (397)
Healthcare (19124)
HIV (74)
Huntington's disease (52)
IgA nephropathy (91)
Immunology and inflammation (271)
Immuno-oncology (81)
Indications (157)
Infectious disease (3065)
Inflammatory bowel disease (201)
Inflation Reduction Act (14)
Influenza (129)
Intellectual property (274)
Interviews (319)
IPO (16808)
IRA (51)
Job creations (3706)
Job search strategy (1442)
JPM (58)
Kidney cancer (18)
Labor market (92)
Layoffs (556)
Leadership (34)
Legal (8003)
Liver cancer (100)
Longevity (28)
Lung cancer (718)
Lymphoma (407)
Machine learning (52)
Management (59)
Manufacturing (920)
MASH (177)
Medical device (14004)
Medtech (14082)
Mergers & acquisitions (20317)
Metabolic disorders (1410)
mRNA (173)
Multiple sclerosis (173)
NASH (17)
Neurodegenerative disease (381)
Neuropsychiatric disorders (97)
Neuroscience (3154)
Neurotech (1)
NextGen: Class of 2026 (6568)
Non-profit (4585)
Now hiring (73)
Obesity (662)
Opinion (277)
Ovarian cancer (186)
Pain (227)
Pancreatic cancer (255)
Parkinson's disease (338)
Partnered (33)
Patents (553)
Patient recruitment (589)
Peanut (61)
People (59931)
Pharmaceutical (60)
Pharmacy benefit managers (32)
Phase 1 (21943)
Phase 2 (31000)
Phase 3 (23074)
Pipeline (7121)
Policy (303)
Postmarket research (2569)
Preclinical (9316)
Press Release (66)
Prostate cancer (281)
Psychedelics (50)
Radiopharmaceuticals (311)
Rare diseases (990)
Real estate (6055)
Recruiting (70)
Regulatory (25217)
Reports (54)
Research institute (2448)
Resumes & cover letters (355)
Rett syndrome (32)
RNA editing (17)
RSV (85)
Schizophrenia (165)
Series A (271)
Series B (201)
Service/supplier (11)
Sickle cell disease (106)
Special edition (22)
Spinal muscular atrophy (164)
Sponsored (46)
Startups (3706)
State (2)
Stomach cancer (18)
Supply chain (117)
Tariffs (85)
The Weekly (58)
Vaccines (1056)
Venture capital (100)
Weight loss (420)
Women's health (109)
Worklife (19)
Date
Today (42)
Last 7 days (638)
Last 30 days (2674)
Last 365 days (30183)
2026 (8040)
2025 (30440)
2024 (35512)
2023 (40432)
2022 (51556)
2021 (56112)
2020 (54593)
2019 (46981)
2018 (35412)
2017 (32525)
2016 (31995)
2015 (38125)
2014 (31800)
2013 (26924)
2012 (29109)
2011 (29808)
2010 (27791)
Location
Africa (755)
Alabama (90)
Alaska (7)
Arizona (333)
Arkansas (13)
Asia (40243)
Australia (6600)
California (12319)
Canada (3517)
China (1229)
Colorado (524)
Connecticut (523)
Delaware (366)
Europe (87603)
Florida (1854)
Georgia (400)
Hawaii (3)
Idaho (62)
Illinois (964)
India (80)
Indiana (562)
Iowa (23)
Japan (490)
Kansas (131)
Kentucky (45)
Louisiana (39)
Maine (73)
Maryland (1486)
Massachusetts (8798)
Michigan (346)
Minnesota (683)
Mississippi (6)
Missouri (141)
Montana (33)
Nebraska (29)
Nevada (136)
New Hampshire (86)
New Jersey (3278)
New Mexico (30)
New York (3248)
North Carolina (1605)
North Dakota (9)
Northern California (6068)
Ohio (368)
Oklahoma (22)
Oregon (41)
Pennsylvania (2483)
Puerto Rico (26)
Rhode Island (50)
South America (1129)
South Carolina (76)
South Dakota (1)
Southern California (4860)
Tennessee (202)
Texas (1942)
United States (43700)
Utah (373)
Vermont (1)
Virginia (292)
Washington D.C. (80)
Washington State (1003)
West Virginia (4)
Wisconsin (132)
Wyoming (2)
735,573 Results for "aurora diagnostics inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Gene editing
Startup Aurora Seeks To Replicate Baby KJ Success With $16M in Seed Money
Aurora joins the clutch of companies linked to Nobel Prize winner and CRISPR trailblazer Jennifer Doudna.
January 12, 2026
·
2 min read
·
Tristan Manalac
Press Releases
Aurora Spine Corporation to Participate in the 38th Annual ROTH Conference
March 16, 2026
·
3 min read
Press Releases
Aurora Spine Announces Issuance of Two U.S. Patents
January 8, 2026
·
4 min read
Press Releases
Aurora Therapeutics Launches to Realize Potential of Personalized Gene Editing for Millions of Patients with Rare Diseases
January 9, 2026
·
6 min read
Press Releases
Aurora Spine Launches New Biologics Portfolio
October 28, 2025
·
4 min read
Press Releases
Aurora Spine Announces Proposed Warrant Extension
October 20, 2025
·
3 min read
Press Releases
Cardio Diagnostics Holdings, Inc. to Host Investor Call on Wednesday, February 18, 2026
February 17, 2026
·
2 min read
Press Releases
CORRECTING and REPLACING Cardio Diagnostics Holdings, Inc. to Host Investor Call on Thursday, February 19, 2026
February 18, 2026
·
2 min read
Press Releases
Ultragenyx Announces First Patient Dosed in Aurora Study Evaluating GTX-102 in Additional Angelman Syndrome Genotypes and Age Groups
October 31, 2025
·
8 min read
Press Releases
Aurora Spine Announces Launch of its DEXA-L™ Anterior Lumbar Interbody Fusion Device
September 18, 2025
·
4 min read
1 of 73,558
Next
